PubRank

R S Fujinami

Author PubWeight™ 74.92‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. Science 1985 3.68
2 Molecular mimicry in virus infection: crossreaction of measles virus phosphoprotein or of herpes simplex virus protein with human intermediate filaments. Proc Natl Acad Sci U S A 1983 2.12
3 Antiviral antibody reacting on the plasma membrane alters measles virus expression inside the cell. Nature 1979 1.75
4 Two models for multiple sclerosis: experimental allergic encephalomyelitis and Theiler's murine encephalomyelitis virus. J Neuropathol Exp Neurol 1996 1.67
5 A neutralization-resistant Theiler's virus variant produces an altered disease pattern in the mouse central nervous system. J Virol 1989 1.59
6 Mechanism of Theiler's virus-induced demyelination in nude mice. Lab Invest 1986 1.53
7 Three-dimensional structure of Theiler virus. Proc Natl Acad Sci U S A 1992 1.52
8 Infection with vaccinia favors the selection of hybridomas synthesizing autoantibodies against intermediate filaments, one of them cross-reacting with the virus hemagglutinin. J Immunol 1983 1.46
9 Alterations in expression of measles virus polypeptides by antibody: molecular events in antibody-induced antigenic modulation. J Immunol 1980 1.45
10 Apoptosis in acute and chronic central nervous system disease induced by Theiler's murine encephalomyelitis virus. Virology 1997 1.41
11 Theiler's virus infection in nude mice: viral RNA in vascular endothelial cells. J Virol 1988 1.41
12 Direct evidence of a role for amino acid 101 of VP-1 in central nervous system disease in Theiler's murine encephalomyelitis virus infection. J Virol 1991 1.40
13 Alteration of amino acid 101 within capsid protein VP-1 changes the pathogenicity of Theiler's murine encephalomyelitis virus. J Exp Med 1989 1.39
14 Viruses disrupt functions of human lymphocytes. II. Measles virus suppresses antibody production by acting on B lymphocytes. J Exp Med 1986 1.24
15 Prolonged gray matter disease without demyelination caused by Theiler's murine encephalomyelitis virus with a mutation in VP2 puff B. J Virol 2001 1.21
16 The relationship between viral RNA, myelin-specific mRNAs, and demyelination in central nervous system disease during Theiler's virus infection. Am J Pathol 1990 1.20
17 Virus-induced immunosuppression: infection of peripheral blood mononuclear cells and suppression of immunoglobulin synthesis during natural measles virus infection of rhesus monkeys. J Infect Dis 1989 1.19
18 Antibody association with a novel model for primary progressive multiple sclerosis: induction of relapsing-remitting and progressive forms of EAE in H2s mouse strains. Brain Pathol 2000 1.17
19 Characterization of in vitro transcription and transcriptional products of measles virus. J Virol 1987 1.14
20 Failure to cleave measles virus fusion protein in lymphoid cells. J Exp Med 1981 1.13
21 Enhancement of experimental allergic encephalomyelitis (EAE) by DNA immunization with myelin proteolipid protein (PLP) plasmid DNA. J Neuropathol Exp Neurol 1998 1.11
22 Hydrocephalus in mice infected with a Theiler's murine encephalomyelitis virus variant. J Neuropathol Exp Neurol 1997 1.09
23 Monoclonal antibody to Theiler's murine encephalomyelitis virus defines a determinant on myelin and oligodendrocytes, and augments demyelination in experimental allergic encephalomyelitis. J Exp Med 1990 1.08
24 Mapping of the major histocompatibility complex and viral antigens on the plasma membrane of a measles virus-infected cell. Virology 1983 1.07
25 Viral infection and dissemination through the olfactory pathway and the limbic system by Theiler's virus. Am J Pathol 1993 1.07
26 Importance of amino acid 101 within capsid protein VP1 for modulation of Theiler's virus-induced disease. J Virol 1994 1.05
27 Exacerbation of viral and autoimmune animal models for multiple sclerosis by bacterial DNA. Brain Pathol 1999 1.04
28 Restricted virus replication in the spinal cords of nude mice infected with a Theiler's virus variant. J Virol 1991 1.03
29 Viruses can silently prime for and trigger central nervous system autoimmune disease. J Neurovirol 2001 1.03
30 Membrane and cytoplasmic changes in virus-infected cells induced by interactions of antiviral antibody with surface viral antigen. Prog Med Virol 1980 1.02
31 Protection of SJL/J mice from demyelinating disease mediated by Theiler's murine encephalomyelitis virus. Microb Pathog 1995 1.00
32 Immune reactive measles virus polypeptides on the cell's surface: turnover and relationship of the glycoproteins to each other and to HLA determinants. J Immunol 1981 0.98
33 Theiler's viruses with mutations in loop I of VP1 lead to altered tropism and pathogenesis. J Virol 1999 0.98
34 Antigenic modulation induced by monoclonal antibodies: antibodies to measles virus hemagglutinin alters expression of other viral polypeptides in infected cells. J Immunol 1984 0.97
35 Alterations in cytokine but not chemokine mRNA expression during three distinct Theiler's virus infections. J Neuroimmunol 2000 0.96
36 Common immunologic determinant between human immunodeficiency virus type 1 gp41 and astrocytes. J Virol 1991 0.96
37 Pathogenesis of Theiler's murine encephalomyelitis virus. Adv Virus Res 1991 0.95
38 Enhancement of autoimmune disease using recombinant vaccinia virus encoding myelin proteolipid protein. J Neuroimmunol 1993 0.94
39 Molecular mimicry: a mechanism for autoimmune injury. FASEB J 1992 0.93
40 Viruses as triggers of autoimmunity: facts and fantasies. Curr Opin Microbiol 1999 0.91
41 Purification of measles virus glycoproteins and their integration into artificial lipid membranes. J Gen Virol 1981 0.91
42 Measles virus infection of human T cells modulates cytokine generation and IL-2 receptor alpha chain expression. Virology 1997 0.91
43 Replacement of loop II of VP1 of the DA strain with loop II of the GDVII strain of Theiler's murine encephalomyelitis virus alters neurovirulence, viral persistence, and demyelination. J Virol 1998 0.91
44 Serologic relatedness between Thy-1.2 and actin revealed by monoclonal antibody. J Immunol 1983 0.89
45 DNA vaccination against Theiler's murine encephalomyelitis virus leads to alterations in demyelinating disease. J Virol 1999 0.88
46 Cellular transfer of experimental allergic encephalomyelitis employing suckling and adult Lewis rats. J Clin Lab Immunol 1981 0.87
47 Experimental allergic encephalomyelitis in suckling Lewis rats: comparison with the disease in adult animals. Lab Invest 1977 0.87
48 Suppression of antigen-specific T cell proliferation by measles virus infection: role of a soluble factor in suppression. Virology 1998 0.86
49 Induction of experimental allergic encephalomyelitis in suckling Lewis rats: role of age and type of sensitizing neuroantigen. J Immunol 1977 0.86
50 Lipopeptide particles as the immunologically active component of CTL inducing vaccines. Vaccine 1999 0.85
51 Nitric oxide synthase inhibitor, aminoguanidine, reduces inflammation and demyelination produced by Theiler's virus infection. J Neuroimmunol 1998 0.85
52 Contrasting effects of anti-adhesion molecule therapy in experimental allergic encephalomyelitis and Theiler's murine encephalomyelitis. J Neuroimmunol 1999 0.83
53 Gender variations in early Theiler's virus induced demyelinating disease: differential susceptibility and effects of IL-4, IL-10 and combined IL-4 with IL-10. J Neuroimmunol 1998 0.83
54 Effects of regional spinal X-irradiation on demyelinating disease caused by Theiler's virus, mouse hepatitis virus or experimental allergic encephalomyelitis. J Neuroimmunol 1987 0.83
55 Antigenic mimicry between measles virus and human T lymphocytes. J Infect Dis 1987 0.83
56 Antisense-mediated resistance to measles virus infection in HeLa cells. J Infect Dis 1997 0.82
57 B-lymphocyte requirement for vaccine-mediated protection from Theiler's murine encephalomyelitis virus-induced central nervous system disease. J Virol 1995 0.82
58 Virus encoding an encephalitogenic peptide protects mice from experimental allergic encephalomyelitis. J Neuroimmunol 1996 0.82
59 Myelin basic protein serum factor. An endogenous neuroantigen influencing development of experimental allergic encephalomyelitis in Lewis rats. J Exp Med 1978 0.82
60 Enhancement of EAE and induction of autoantibodies to T-cell epitopes in mice infected with a recombinant vaccinia virus encoding myelin proteolipid protein. J Neuroimmunol 1997 0.82
61 Infection with a recombinant vaccinia virus encoding myelin proteolipid protein causes suppression of chronic relapsing-remitting experimental allergic encephalomyelitis. J Neuroimmunol 1999 0.81
62 MBP-SF, a prominent serum factor in suckling Lewis rats that additively inhibits the primary binding of myelin basic protein (MBP) to syngeneic anti-MBP antibodies. Immunochemistry 1978 0.80
63 Peripheral nerve protein, P0, as a potential receptor for Theiler's murine encephalomyelitis virus. J Neurovirol 2001 0.80
64 Immunologic determinants of experimental neurologic autoimmune disease and approaches to the multiple sclerosis problem. Trans Am Clin Climatol Assoc 1978 0.79
65 Antigenic modulation: a mechanism of viral persistence. Prog Brain Res 1983 0.79
66 Rapid accumulation of measles virus leader RNA in the nucleus of infected HeLa cells and human lymphoid cells. J Virol 1991 0.78
67 Theiler's murine encephalomyelitis virus contrasts with encephalomyocarditis and foot-and-mouth disease viruses in its functional utilization of the StopGo non-standard translation mechanism. J Gen Virol 2012 0.77
68 Immune responses against myelin basic protein and/or galactocerebroside cross-react with viruses: implications for demyelinating disease. Curr Top Microbiol Immunol 1989 0.77
69 Lack of correlation of Theiler's virus binding to cells with infection. J Neurovirol 1997 0.77
70 Immunity to viruses. Curr Opin Immunol 1989 0.75
71 Characterization of a murine central nervous system-derived cell line: infectability and presentation of viral antigen. J Neuroimmunol 1994 0.75
72 DNA immunization and central nervous system viral infection. Adv Virus Res 2001 0.75
73 Enhancement of autoimmune disease using recombinant vaccinia virus encoding myelin proteolipid protein. J Neuroimmunol 1993 0.75
74 Lack of suppressive effect of alpha-foetoprotein on development of experimental allergic encephalomyelitis in rats. Nature 1977 0.75
75 Immunity to viruses. Curr Opin Immunol 1990 0.75